Physicochemical characterisation of a novel thermogelling formulation for percutaneous penetration of 5-aminolevulinic acid

Journal of Pharmaceutical Sciences

Volumn 97, Issue 6, 2008, Pages 2311-2323

  Crüning, Nadja ^a   Müller Goymann, Christel Charlotte ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

5 aminolevulinic acid; Calorimetry (DSC); Drug transport; Formulation vehicle; Permeability; Permeation enhancers; Rheology; Skin; Thermal gels

Indexed keywords

2 PROPANOL; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; COPOLYMER; DIMETHYL ISOSORBIDE; IBUPROFEN; MEDIUM CHAIN TRIACYLGLYCEROL; POLOXAMER; UNCLASSIFIED DRUG; WATER; DERMATOLOGICAL AGENT; DRUG CARRIER; DRUG DERIVATIVE; ISOSORBIDE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONCENTRATION RESPONSE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG TRANSPORT; FEMALE; FLOW MEASUREMENT; HUMAN; HUMAN TISSUE; LIQUID CRYSTAL; PHYSICAL CHEMISTRY; STRATUM CORNEUM; CHEMISTRY; FLOW KINETICS; GEL; INTRADERMAL DRUG ADMINISTRATION; KINETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; OINTMENT; PERMEABILITY; PHARMACEUTICS; SKIN ABSORPTION; TEMPERATURE;

2-PROPANOL; ADMINISTRATION, CUTANEOUS; AMINOLEVULINIC ACID; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; DERMATOLOGIC AGENTS; DRUG CARRIERS; DRUG COMPOUNDING; FEMALE; GELS; HUMANS; ISOSORBIDE; KINETICS; LIQUID CRYSTALS; MIDDLE AGED; OINTMENTS; PERMEABILITY; POLOXAMER; RHEOLOGY; SKIN ABSORPTION; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE; TRIGLYCERIDES; WATER;

EID: 49249107085     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21157     Document Type: Article

References (48)

1. Laboratorium Galderma 1 Auflage Juni 2002 Nachdruck Januar 2003. Wissenschaftliche Basisinformation Metvix/Aktilite 2002.
2. Uehlinger P, Zellwegger M, Wagnières G, Juillerat-Jeanneret L, van den Bergh H, Lange N. 2000. 5-Aminolevulinic acid and its derivatives: Physical chemical properties and protoporphyrin IX formation in cultured cells. J Photochem Photobiol B 54:72-80.
3. Winkler A, Müller-Goymann CC. 2005. The influence of topical formulations on the permeation of 5-aminolevulinic acid and its n-butyl ester through excised human stratum corneum. Eur J Pharm Biopharm 60:427-438.
4. De Rosa FS, Tedesco AC, Lopez RFV, Pierre MBR, Lange N, Marchetti JM, Rotta JCG, Bentley MVLB. 2003. In vitro permeation and retention of 5-aminolevulinic acid ester derivatives for photodynamic therapy. J Control Release 89:261-269.
5. van den Akker J, Jani V, Star W, Sterenborg H, Moan J. 2000. Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic to normal nude mouse skin: Differences in Protoporphyrin EX fluorescence kinetics and the role of the stratum corneum. Photochem Photobiol 72:681-689.
6. Perotti C, Casas A, Fukuda H, Sacca P, Batlle A. 2003. Topical application of LA and ALA hexyl ester on a subcutaneous murine mammary adenocarcinoma: Tissue distribution. Br J Cancer 88:432-437.
7. Casas A, Battle A. 2006. Aminolevulinic acid derivatives and liposome delivery as strategies for improving 5-aminolevulinic acid-mediated photo-dynamic therapy. Curr Med Chem 13:1157-1168.
8. Battah S, Balaratnam S, Casas A, O'Neill S, Edwards C, Battle A, Dobbin P, MacRobert AJ. 2007. Macromolecular delivery of 5-aminolaevulinic acid for photodynamic therapy using dendrimer conjugates. Mol Cancer Ther 6:876-884.
9. Gilmore BF, McCarron PA, Morrow DIJ, Murphy DJ, Woolfson AD, Donnelly RF. 2006. In vitro phototoxicity of 5-aminolevulinic acid and its methyl ester and the influence of barrier properties on their release from a bioadhesive patch. Eur J Pharm Biopharm 63:295-309.
10. Lieb S, Szeimies R-M, Lee G. 2002. Self-adhesive thin films for topical delivery of 5-aminolevulinic acid. Eur J Pharm Biopharm 53:99-106.
11. Valenta C, Auner BG, Loibl I. 2005. Skin permeation and stability studies of 5-aminolevulinic acid in a new gel and patch preparation. J Control Release 107:495-501.
12. Merclin N, Bramer T, Edsman K. 2004. Iontophoretic delivery of 5-aminolevulinic acid and its methyl ester using a carbopol gel as vehicle. J Control Release 98:57-65.
13. Merclin N, Bender J, Sparr E, Guy RH, Ehrsson H, Engström S. 2004. Transdermal delivery from a sponge phase-iontophoretic and passive transport of 5-aminolevulinic acid and its methyl ester. J Control Release 100:191-198.
14. Turchiello RF, Vena FCB, Maillard Ph, Souza CS, Bentley MVBL, Tedesco AC. 2003. Cubic phase gel as a drug delivery system for topical application of 5-ALA, its ester derivatives and m-THPC in photo-dynamic therapy (PDT). J Photochem Photobiol B 70:1-6.
15. Casas A, Fukuda H, Di Venosa G, Battle AMDELC. 2000. The influence of the vehicle on the synthesis of porphyrins after topical application of 5-amino-laevulinic acid. Implications in cutaneous phto-dynamic sensitization. Br J Dermatol 143:564-572.
16. De Rosa FS, Marchetti JM, Thomazini JA, Tedesco AC, Bentley MVLB. 2000. A vehicle for photodynamic therapy of skin cancer: Influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy. J Control Release 65:359-366.
17. Malik Z, Kostenich G, Roitman L, Ehrenberg B, Orenstein A. 1995. Topical application of 5-aminolevulinic acid, DMSO and EDTA: Protoporphyrin IX accumulation in skin and tumours of mice. J Photochem Photobiol B 28:213-218.
18. Fijan S, Hönigsmann H, Ortel B. 1995. Photo-dynamic therapy of epithelial skin tumours using delta-aminolevulinic acid and desferrioxamine. Br J Dermatol 133:282-288.
19. Schleier P, Hyckel P, Berndt A, Bode H-P, Albrecht V, Hindermann W, Kosmehl H, Zenk W, Schumann D. 2004. Photodynamic therapy of virus-associated epithelial tumours of the face in organ transplant recipients. J Cancer Res Clin Oncol 130:279-284.
20. Andikyan V, Kronschnabl M, Hillemanns M, Wang X, Stepp H, Hillemanns P. 2004. Fluorescence diagnosis with 5-ALA thermogel of cervical intraepithelial neoplasia. Gynäkol Geburtshilfliche Rundsch 44:31-37.
21. Deutscher Arzneimittelcodex (DAC) 2006. Govi Verlag, Eschborn 1, B-020
22. Deutsches Arzneibuch (DAB) 2006. Govi-Verlag, Eschborn.
23. Medac GmbH 2004. Sicherheitsdatenblatt 5-ALA according to 91/155//EG
24. Kligman AM, Christophers E. 1963. Preparation of isolated sheets of human stratum corneum. Arch Dermatol 88:702-705.
25. Franz TJ. 1975. Percutaneous absorption. On the relevance of in vitro data. J Invest Dermatol 64: 190-195.
26. Pharmacopoea Helvetica 1997. Deutsche Ausgabe. 8
27. Novo M, Hüttmann G, Diddens H. 1996. Chemical instability of 5-aminolevulinic acid used in the fluorescence diagnosis of bladder tumours. J Photochem Photobiol B 24:143-148.
28. Granick S, Mauzerall D. 1958. Porphyrin biosynthesis in erythrocytes. II. Enzymes converting δ-aminolevulinic acid to coproporphyrinogen. J Biol Chem 232:1119-1140.
29. Winkler A. 2005. Untersuchungen zur Permeation von 5- Aminolävulinsäure (5-ALA) und 5-ALA-n-butylester durch exzidiertes humanes Stratum corneum und organotypisches Hautkonstrukt. Dissertation:64ff.
30. Winkler A, Müller-Goymann CC. 2002. Comparative permeation studies for δ-aminolevulinic acid and its butyl-ester through stratum corneum and artificial skin constructs. Eur J Pharm Biopharm 53:281-287.
31. Ho J, Guthrie R, Tieckelmann H. 1986. Detection of δ-aminolevulinic acid, porphobilinogen and porphyrins related to heme biosynthesis by high-performance liquid chromatography. J Chromatogr 375:57-63.
32. Ricci EJ, Bentley MVLB, Farah M, Bretas RES, Marchetti JM. 2002. Rheological characterization of Poloxamer 407 lidocaine hydrochloride gels. Eur J Pharm Sci 17:161-167.
33. a copolymer (poloxamer 407) aqueous solutions. J Colloid Interf Sci 190: 307-312.
34. Kabanov AV, Batrakova EV, Alakhov VYu. 2002. Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release 82:189-212.
35. Mezger T. 2000. Das Rheologie-Handbuch. Hannover: Vincentz-Verlag.
36. Valenta C, Schultz K. 2004. Influence of carrageenan on the rheology and skin permeation of microemulsion formulations. J Control Release 95:257-265.
37. Flynn GL, Yalkowsky SH, Roseman TJ. 1974. Mass transport phenomena and models: Theoretical concepts. J Pharm Sci 63:479-510.
38. Winkler A, Müller-Goymann CC. 2005. The influence of topical formulations on the permeation of 5-aminolevulinic acid and its n-butyl ester through excised human stratum corneum. Eur J Pharm Biopharm 60:427-438.
39. Junginger H, Heering W, Führer C, Geffers I. 1981. Elektronenmikroskopische Untersuchungen über den kolloidchemischen Aufbau von Salben und Cremes. Colloid Polym Sci 259:561-567.
40. Müller-Goymann CC. 2004. Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration. Eur J Pharm Biopharm 58:343-356.
41. Burger A. 1982. DTA und DSC Grundlagen, Methodik und Anwendung. Pharmazie in unserer Zeit 11:177-189.
42. Brinkmann I, Müller-Goymann CC. 2003. Role of isopropyl myristate, isopropyl alcohol and a combination of both in hydrocortisone permeation across human stratum corneum. Skin Pharmacol Appl Skin Physiol 16:393-404.
43. Bouwstra JA, de Vries MA, Gooris GS, Bras W, Brussee J, Ponec M. 1991. Thermodynamic and structural aspects of the skin barrier. J Control Release 15:209-220.
44. Knutson K, Potts RO, Guzek DB, Golden GM, McKie JE, Lambert WJ, Higuchi WI. 1985. Macro and molecular physical-chemical considerations in understanding drug transport in the stratum corneum. J Control Release 2:67-87.
45. Barry BW. 1987. Mode of action of penetration enhancers in human skin. J Control Release 6: 85-97.
46. Golden GM, Guzek DB, Harris RR, McKie JE, Potts RO. 1986. Lipid thermotropic transitions in human stratum corneum. J Invest Dermatol 86:255-259.
47. Bouwstra JA, Gooris GS, Bras W. 1993. New insights in the lipid structure of the skin barrier. In: Gurney R, Teubner A, editors. Dermal transdermal drug delivery. Stuttgart: Wissenschaftliche Verlagsgesellschaft. Vol. III, pp 67-90.
48. Leopold CS, Lippold BC. 1995. An attempt to clarify the mechanism of the penetration effects of lipophilic vehicles with differential scanning calorimetry (DSC). J Pharm Pharmacol 47:276-281.